IM Cannabis Corp (TSE:IMCC) has released an update.
IM Cannabis Corp reports significant growth in Germany’s medical cannabis market following partial legalization, with a 182% increase in 2023 outperforming the market considerably. The company has secured a new EU-GMP certified supplier, GlassHouse Botanics, to support its expanding supply chain. Management is now focusing on strengthening Israeli and German operations and preparing for future expansion into the European medical and potential recreational cannabis markets.
For further insights into TSE:IMCC stock, check out TipRanks’ Stock Analysis page.
